Jump to main content.


Pesticide Registration Improvement Renewal Act (PRIA 2)
Fee Determination Decision Tree

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

Decision Tree Resources:
Below is the fee for your selected Fee Category for
Fiscal Year 2011 & 2012

Action Code
Description
FY11/FY12
Fee
FY11/FY12 Decision Time
(months)
R300
New product; identical or substantially similar in composition and use to a registered product; no data review or only product chemistry data; cite-all data citation, or selective data citation where applicant owns all required data, or applicant submits specific authorization letter from data owner. Category also includes 100% re-package of registered end use or manufacturing-use product that requires no data submission nor data matrix
$1,434.00
3


Do you plan to request either of the following types of waivers?

50% waiver 50% waiver
75% waiver 75% waiver

To pay the fee shown above, go to http://www.pay.gov and follow the instructions.

How to submit your application directly to EPA.


Action Code Interpretation:

An application for registration of an end-use or a manufacturing use pesticide product that is substantially similar or identical in its uses and/or formulation to products that are currently registered or differ only in ways that would not significantly increase the risk of unreasonable adverse effects.  The applicant must identify the similar products for all active ingredients in the proposed product.  All applications require the following: 

  • A data matrix is required with the application.
  • Product chemistry data (Group A and B) (2 pp, 105K, About PDFs) unless the product is identical (e.g. 100% repackaged product).  In some cases product chemistry data can be satisfied as outlined in Pesticide Registration Notice 98-1 (9 pp, 22.3 MB, About PDF).
  • All inert ingredients must already be approved for the applicable uses in the product.
  • The active ingredient listed on the CSF must be an EPA registered product.
  • In all cases, the applicant must identify the currently registered similar product for this category.
  • Acute toxicity requirements must be addressed by using:  1) cite-all method or 2) selective data citation where the applicant owns all required data or; the applicant submits specific authorization letter from data owner.

 
The application is not in this category if efficacy, acute toxicity, companion animal safety, and/or child resistant packaging data are submitted and must be reviewed to support the application.  The application does not fall into this category if it contains a request to waive any of these data.  An application that requires review of cited or submitted data other than product chemistry does not belong in this fee category.

Substantially similar: Product must have the same active ingredient, in substantially the same proportion, same chemical composition (solid, liquid, granular), and substantially similar inert ingredients as the already registered product.  In addition, substantially similar means that the proposed product bears the same use patterns.  Adding to or changing existing use patterns exclude the proposed product from treatment as a substantially similar product.  Deleting use patterns is acceptable.

Identical: Same composition and use patterns as a currently registered end use product.

Manufacturing Use Product:  A 100% re-package of a manufacturing use product that requires no data submission or data matrix is covered by this category.

Back      Go to the start of the Decision Tree

Publications | Glossary | A-Z Index | Jobs


Local Navigation


Jump to main content.